Insmed H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Bridgewater, NJ HQ🌐 insmed.com
Does Insmed sponsor H-1B visas and green cards?
Yes. Insmed has filed 74 H-1B LCAs and 11 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 Insmed filed 31 H-1B LCAs at a median base salary of $152,000, about 25% above the national H-1B median of $121,966 for the same period, and 6 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 11 | $146k |
| FY2025 | 20 | $156k |
| FY2024 | 6 | $163k |
| FY2023 | 14 | $142k |
| FY2022 | 8 | $139k |
| FY2021 | 1 | $160k |
| FY2020 | 5 | $118k |
| FY2019 | 3 | $105k |
| FY2018 | 3 | $155k |
| FY2017 | 3 | $115k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1Scientist6$110k
- 2Associate Director, HEOR4$183k
- 3Associate Director, Biostatistics3$214k
- 4Associate Director, Business Intelligence & Data Warehousing3$181k
- 5Associate Director, Clinical Systems & Business Intelligence3$174k
- 6Associate Scientist3$111k
- 7Senior Manager, Cybersecurity3$181k
- 8Associate Director, Cybersecurity2$189k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 5 | $128k |
| FY2025 | 1 | $170k |
| FY2024 | 1 | $160k |
| FY2022 | 3 | $128k |
| FY2020 | 1 | $119k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 65
- US patents
- Published, not yet granted
- 140
- applications
- Most recent grant
- January 13, 2026
- Top area
- Preparations for medical52
Pay against the local market
Insmed’s most-filed occupations and metros, FY2021–FY2026. Its median base salary is 133% of the local BLS median for the same work.
| Occupation | Metro | Filings | Insmed pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Information Security Analysts | Durham, NC | 2 | $170,690 | $130,735 | 131% |
| Computer and Information Systems Managers | Raleigh, NC | 1 | $160,000 | $151,870 | 105% |
| Computer Systems Analysts | San Diego, CA | 1 | $122,000 | $110,840 | 110% |
| Industrial Production Managers | Allentown, PA | 1 | $144,900 | $109,740 | 132% |
| Bioengineers and Biomedical Engineers | San Diego, CA | 1 | $145,670 | $116,790 | 125% |
| Statisticians | Boston, MA | 1 | $210,000 | $99,230 | 212% |
| Information Security Analysts | Raleigh, NC | 1 | $181,380 | $115,990 | 156% |
| Natural Sciences Managers | Boston, MA | 1 | $214,200 | $219,380 | 98% |
About Insmed
Insmed is a pharma & biotech company based in Bridgewater Township. It was founded in 1988. It is listed on Nasdaq as INSM.
- Legal name
- INSMED Inc
- Listed
- Nasdaq: INSM
- Incorporated in
- Virginia
- Headquarters
- 700 Us Highway 202/206, Bridgewater, NJ 08807
- Industry
- Pharma & biotech
- Employees (global)
- 1,664 (2025)
- Revenue FY2025
- $606M +67% from $364M
- Net income FY2025
- $-1.3B -40% from $-914M
- R&D FY2025
- $771M (127% of revenue)
Insmed pays a median H-1B base of $145,000 across FY2017–2026, about 35% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to Insmed
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Ensymbios | 104 | 7 | $103k | 1 | — |
| Bitech | 98 | 5 | $112k | 1 | — |
| Sana Biotechnology | 93 | 22 | $136k | 7 | 76% |
| Insmed | 74 | 31 | $152k | 7 | 84% |
| BioNTech | 74 | 26 | $124k | 4 | 50% |
| GreenLight Biosciences | 74 | 5 | $100k | 3 | — |
| Karyopharm Therapeutics | 74 | 12 | $147k | 1 | — |
